Di Pisa, F., Landi, G., L. Iacono, D., Pozzi, C., et al. (2017). Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity. Molecules, 22(3).

Belo, R., Santarém, N., Pereira, C., Pérez-Cabezas, B., et al. (2017). Leishmania infantum exoproducts inhibit human invariant NKT cell expansion and activation. Frontiers in Immunology, 8(JUN).

Borsari, C., Santarém, N., Torrado, J., Olías, A. I., et al. (2017). Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds. European Journal of Medicinal Chemistry, 126, 1129 - 1135.

Lima, C., Mesquita, J. R., Brancal, H., Vahlenkamp, T., et al. (2017). The use of Escherichia coli total antigens as a complementary approach to address seropositivity to Leishmania antigens in canine leishmaniosis. Parasitology, 144(10), 1384 - 1393.

Faria, J., Loureiro, I., Santarém, N., Ceclio, P., et al. (2016). Disclosing the essentiality of ribose-5-phosphate isomerase B in Trypanosomatids. Scientific Reports, 6.

Faria, J., Loureiro, I., Santarém, N., Macedo-Ribeiro, S., et al. (2016). Leishmania infantum Asparagine Synthetase A Is Dispensable for Parasites Survival and Infectivity. PLoS Neglected Tropical Diseases, 10(1).

Borsari, C., Lucian, R., Pozzi, C., Poehner, I., et al. (2016). Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs. Journal of Medicinal Chemistry, 59(16), 7598 - 7616.

Loureiro, I., Faria, J., Clayton, C., Macedo-Ribeiro, S., et al. (2015). Ribose 5-Phosphate Isomerase B Knockdown Compromises Trypanosoma brucei Bloodstream Form Infectivity. PLoS Neglected Tropical Diseases, 9(1).

Santarém, N., Racine, G., Silvestre, R., Cordeiro-da-Silva, A., & Ouellette, M. (2013). Exoproteome dynamics in Leishmania infantum. Journal of Proteomics, 84, 106 - 118.

Moreira, D., Santarém, N., Loureiro, I., Tavares, J., et al. (2012). Impact of continuous axenic cultivation in Leishmania infantum virulence. PLoS Neglected Tropical Diseases, 6(1).

Santarém, N., Silvestre, R., Cardoso, L., Schallig, H., et al. (2010). Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis. Journal of Clinical Microbiology, 48(5), 1866 - 1874.

Silvestre, R., Santarém, N., Teixeira, L., Cunha, J., et al. (2009). Evaluation of Leishmania species reactivity in human serologic diagnosis of leishmaniasis. American Journal of Tropical Medicine and Hygiene, 81(2), 202 - 208.

Carvalho, S., Cruz, T., Santarém, N., Castro, H., et al. (2009). Heme as a source of iron to Leishmania infantum amastigotes. Acta Tropica, 109(2), 131 - 135.

Silvestre, R., Santarém, N., Tavares, J., Silva, A. M., & Cordeiro-da-Silva, A. (2009). Recognition of Leishmania parasites by innate immunity. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, 9(2), 106 - 127.

Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., et al. (2008). Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 69(2), 405 - 416.

Tavares, J., Ouaissi, A., Santarém, N., Sereno, D., et al. (2008). The Leishmania infantum cytosolic SIR2-related protein 1 (LiSIR2RP1) is an NAD+-dependent deacetylase and ADP-ribosyltransferase. Biochemical Journal, 415(3), 377 - 386.

Silvestre, R., Santarém, N., Cunha, J., Cardoso, L., et al. (2008). Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry. Veterinary Parasitology, 158(1-2), 23 - 30.

Santarém, N., Silvestre, R., Tavares, J., Silva, M., et al. (2007). Immune response regulation by Leishmania secreted and nonsecreted antigens. Journal of Biomedicine and Biotechnology, 2007.

Silvestre, R., Cordeiro-da-Silva, A., Santarém, N., Vergnes, B., et al. (2007). SIR2-deficient Leishmania infantum induces a defined IFN-?/IL-10 pattern that correlates with protection. Journal of Immunology, 179(5), 3161 - 3170.

Santarém, N., Tomás, A., Ouaissi, A., Tavares, J., et al. (2005). Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunology Letters, 101(1), 18 - 23.